Comparing Estarylla vs Opill
Estarylla (ethinyl estradiol / norgestimate) | Opill (norgestrel) |
|
---|
Estarylla (ethinyl estradiol / norgestimate) | Opill (norgestrel) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Acne, Endometriosis, Ovarian Cysts, Abnormal Uterine Bleeding, Birth Control, Gonadotropin Inhibition. Estarylla may also be used for purposes not listed in this medication guide. |
Over-the-counter
Prescribed for Birth Control. Opill may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||
More about (ethinyl estradiol / norgestimate) | More about Opill (norgestrel) | ||||||||
Ratings & Reviews | |||||||||
Estarylla has an average rating of 3.7 out of 10 from a total of 530 ratings on Drugs.com. 22% of reviewers reported a positive effect, while 64% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Estarylla side effects |
View all Opill side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
Lower cost generic approved |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Opill prices |
||||||||
Dosage Forms | |||||||||
|
|
||||||||
Brand Names | |||||||||
Other ethinyl estradiol / norgestimate brands include: Femynor, Mili, Mono-Linyah, Nymyo, Previfem, Sprintec, Tri Femynor, Tri-Estarylla, Tri-Linyah, Tri-Lo-Estarylla, Tri-Lo-Linyah, Tri-Lo-Marzia, Tri-Lo-Mili, Tri-Lo-Sprintec, Tri-Mili, Tri-Nymyo, Tri-Previfem, Tri-Sprintec, Tri-VyLibra, Tri-Vylibra Lo, VyLibra View more |
N/A |
||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
N/A |
N/A |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
|
||||||||
Drug Interactions | |||||||||
A total of 494 drugs are known to interact with Estarylla:
|
A total of 261 drugs are known to interact with Opill:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
Disease Interactions | |||||||||
|
|||||||||
First Approval Date | |||||||||
N/A |
October 23, 1973 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
N/A |
|||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Premarin
Premarin is used to treat symptoms of menopause such as hot flashes, and vaginal dryness. Learn ...
Mirena
Mirena (levonorgestrel) is a plastic intrauterine device placed in the uterus and is used to ...
Lutathera
Lutathera is a targeted radiotherapy used for gastroenteropancreatic neuroendocrine tumors ...
Provera
Provera is used for abnormal uterine bleeding, amenorrhea, birth control, endometrial cancer ...
Eligard
Eligard (leuprolide) reduces levels of testosterone and is used to treat prostate cancer. Includes ...
Depo Provera
Depo-Provera is used as contraception to prevent pregnancy. It is also used to reduce pain cause by ...
Nexplanon
Nexplanon is a long-term, reversible birth control implant that lasts for three years. Learn about ...
Accutane
Accutane (isotretinoin) is a form of vitamin A and is used to treat severe nodular acne. Includes ...
Sprintec
Sprintec is used for abnormal uterine bleeding, birth control, endometriosis, gonadotropin ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.